Insiders Arcus Biosciences, Inc.

Equities

Delayed Nyse Other stock markets 03:55:07 2024-04-29 pm EDT			5-day change	1st Jan Change
15.79 ^USD	+1.54%		+7.49%	-17.38%

Mar. 12	Transcript : Arcus Biosciences, Inc. Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-12-2024 02:35 PM
Feb. 29	Arcus Biosciences Insider Sold Shares Worth $1,177,967, According to a Recent SEC Filing	MT

Arcus Biosciences Insider Sold Shares Worth $1,177,967, According to a Recent SEC Filing	Feb. 29	MT
Arcus Biosciences Insider Sold Shares Worth $543,187, According to a Recent SEC Filing	Feb. 29	MT
Arcus Biosciences Insider Sold Shares Worth $427,166, According to a Recent SEC Filing	23-09-26	MT
Insider Sell: Arcus Biosciences	23-06-26	MT
Insider Sell: Arcus Biosciences	23-03-20	MT
Arcus Biosciences, Inc. Announces Principal Accounting Officer Changes	23-03-10	CI
Insider Sell: Arcus Biosciences	22-09-20	MT
Arcus Biosciences, Inc. Appoints Dimitry S.A. Nuyten as Chief Medical Officer	22-08-08	CI
Insider Sell: Arcus Biosciences	22-06-21	MT
Insider Sell: Arcus Biosciences	22-06-21	MT
Insider Sell: Arcus Biosciences	22-03-18	MT
Insider Sell: Arcus Biosciences	21-12-22	MT
Insider Sell: Arcus Biosciences	21-12-20	MT
Insider Sell: Arcus Biosciences	21-12-20	MT
Insider Sell: Arcus Biosciences	21-09-22	MT
Arcus Biosciences, Inc. Announces Board Changes	21-08-11	CI
Arcus Biosciences, Inc. Appoints Nicole Lambert to the Board as Class II Director	21-08-05	CI
Bill Grossman, Arcus Biosciences, Inc.'s Chief Medical Officer, Resigns	21-07-19	CI
Insider Trends: Arcus Biosciences Insider Sale Scales Back 90-Days of Buys	21-06-21	MT
Insider Trends: Insider Sale at Arcus Biosciences Slowing 90-Days of Buying	21-06-21	MT

No results for this search